Investment
Features
FeesSafety
Academy
More
Pluang+

Banco Macro SA to report Q2 earnings with mixed analyst views and recent stock drop

Company Fundamentals
19 Aug 2026
Alex Lavoie
View Source
Neutral
Banco Macro SA to report Q2 earnings with mixed analyst views and recent stock drop

Banco Macro SA is set to release its Q2 2026 earnings, with analysts expecting an EPS of $1.71 and revenues near $946 million. The stock has fallen 3.5% recently, contributing to a 12.3% decline year-to-date amid high volatility expectations from options traders. While Zacks rates the stock as a buy, GuruFocus considers it significantly overvalued compared to its estimated intrinsic value. The bank shows a moderate P/E ratio of 19.56 and low debt levels, indicating manageable financial risk as investors await the earnings report.

More News

GameStop insiders buy millions in shares, signaling strong confidence despite stock volatility.

GameStop insiders buy millions in shares, signaling strong confidence despite stock volatility.

GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...

Market News
Bullish
3 hours ago
Concentrix posts strong Q3 EPS but misses revenue estimates, boosts dividend and cash flow.

Concentrix posts strong Q3 EPS but misses revenue estimates, boosts dividend and cash flow.

Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...

Company Fundamentals
Neutral
3 hours ago
Accenture expects 5.6% revenue growth in Q3 2026, driven by strong AI demand and regional gains.

Accenture expects 5.6% revenue growth in Q3 2026, driven by strong AI demand and regional gains.

Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...

Company Fundamentals
Bullish
3 hours ago
Iovance, SoundThinking, and WidePoint stocks surge on revenue upgrades, acquisition deal, and government contract news

Iovance, SoundThinking, and WidePoint stocks surge on revenue upgrades, acquisition deal, and government contract news

Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...

Market News
Bullish
3 hours ago
Stocks fall as uniQure, Fair Isaac, and ClearPoint Neuro lead losses on clinical and regulatory concerns.

Stocks fall as uniQure, Fair Isaac, and ClearPoint Neuro lead losses on clinical and regulatory concerns.

Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...

Market News
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App